Skip to main content
School of Public Health
block W logo University of Washington

Anirban Basu

faculty photo
Professor, Health Services
Professor, Pharmacy (primary appt.)
Adjunct Professor, Economics


PhD   University of Chicago, 2004   (Health Economics, Public Policy)
MS   University of North Carolina (Chapel Hill), 1999   (Biostatistics)
MS   University of Toledo, 1997   (Pharmaceutical Sciences)
BS   Jadavpur University, 1995   (Pharmaceutical Sciences)

Contact Info

web site:

office:   H-375Q, Health Sciences Building

Magnuson Health Sciences Center
1959 NE Pacific St.
Seattle, WA 98195-7630

campus box:   357630
voice:   206-616-2986
fax:   206-543-3964


Anirban Basu's work sits at the intersection of microeconomics, statistics, and health policy. His research focuses on comparative and cost effectiveness analyses, causal inference methods, program evaluation, and outcomes research.

Currently the Stergachis Family Endowed Professor and Director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington, Basu also serves as faculty member in the Department of Health Services and as an adjunct in the Department of Economics. Previously, Basu taught on the faculty of the University of Chicago Department of Medicine, where he remains an external affiliate of the Center for Health and the Social Sciences.

In addition to his position as a faculty research fellow at the National Bureau of Economic Research, Basu is as an associate editor for Health Economics, Journal of Health Economics, and Observational Studies, and has served as panelist or speaker at many economics and health studies conferences, nationally and abroad.

Health econometrics; cost-effectiveness; comparative effectiveness and value of information analyses; quality of life; spill-over effects; substantive focus on cancer, mental health and diabetes
  • HSERV 525
    Advanced Health Services Research Methods III - Causal Inference Using Observational Data

Yeung K, Basu A, Hansen RN, Sullivan SD. Price elasticities of pharmaceuticals in a value based-formulary setting. Health Econ. 2018 Jul 20. doi: 10.1002/hec.3801. [Epub ahead of print]  PMID: 30028050

Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ, Salomon JA, Prosser LA, Owens DK, Meltzer DO, Kuntz KM, Krahn M, Feeny D, Basu A, Russell LB, Siegel JE, Ganiats TG, Sanders GD. Future Directions for Cost-effectiveness Analyses in Health and Medicine. Med Decis Making. 2018 Oct;38(7):767-777. doi: 10.1177/0272989X18798833.  PMID: 30248277

Basu A. Comment: Manski's views on patient care under uncertainty. Health Econ. 2018 Oct;27(10):1422-1424. doi: 10.1002/hec.3808. Epub 2018 Aug 2.  PMID: 30070415

Sabbatini AK, Wright B, Hall MK, Basu A. The cost of observation care for commercially insured patients visiting the emergency department. Am J Emerg Med. 2018 Jan 21. pii: S0735-6757(18)30040-8. doi: 10.1016/j.ajem.2018.01.040. [Epub ahead of print]  PMID: 29366657

Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD. Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study. Cancer Med. 2018 Jul 20. doi: 10.1002/cam4.1657. [Epub ahead of print]  PMID: 30030904    PMCID: PMC6144145
PubMed Central

Chair, dissertation committee for Sungchul Park
Understanding Unintended Consequences of Risk Adjustment and Proposing Alternative Risk Adjustment

Chair, dissertation committee for Benjamin Ely
Antibiotics and acute respiratory tract infections: a policy evaluation of the CDC’s Get Smart about Antibiotics campaign.

Member, dissertation committee for Sarah Beth Barnett
Economic evaluations of state and local policies: Depression and related outcomes in populations of vulnerable adults

Chair, dissertation committee for David Kim
Loss relative to Efficient Diffusion (LED) - A novel metric for economic evaluation of medical technology and its application to the evaluation of bariatric surgery

Chair, thesis committee for Wei-Jhih Wang
What guides research investments in translational sciences? The case for pharmaceuticals in metastatic cancers

Comparative Effectiveness of Dynamic Patterns of Glucose Lowering Therapies
University of Chicago
PI:   Basu           Dates:    6/1/2016 - 5/30/2017

Innovative Methods for Modeling Lognitudinal Medical Costs
Northwestern University
PI:   Basu           Dates:    9/1/2015 - 8/31/2016

Personalized Medicine Economics Research PriMER
National Institute on Aging (NIA)
PI:   Veenstra           Dates:    7/1/2015 - 6/30/2016

Current and Future Costs of Alzheimer's and Dementia Care
National Institutes of Health (NIH)
PI:   Coe           Dates:    7/1/2015 - 6/30/2019

Comparative Effectiveness of Dynamic Patterns of Glucose Lowering Therapies
University of Chicago
PI:   Basu           Dates:    6/1/2015 - 5/31/2016

WWAMI Practice Transformation Network
Centers for Medicare and Medicaid Services (CMS)
PI:   Flum           Dates:    5/1/2015 - 4/30/2019

Data De-Identification Services 2015-2017
King County Executive
PI:   Basu           Dates:    2/1/2015 - 1/31/2017

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
National Institutes of Health (NIH)
PI:   Zatzick           Dates:    7/1/2014 - 6/30/2019

Personalized Medicine Economics Research (PriMER)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
PI:   Veenstra           Dates:    10/1/2013 - 9/30/2018

Innovative Methods for Modeling Longitudinal Medical Costs
Northwestern University
PI:   Basu           Dates:    12/28/2011 - 8/31/2016

Graduate Certificate in Comparative Effectiveness Research

Comparative effectiveness research is a growing field that aims to generate evidence to improve health care decisions for patients and providers. It examines the benefits and risks of different medical or healthcare interventions, including drugs and medical technology. The results of these comparison studies are used by medical professionals to make better informed healthcare decisions and thereby improve patient care.